In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose...
-
2014 (v1)PublicationUploaded on: April 14, 2023
-
2007 (v1)Publication
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations among patients with juvenile parkinsonism (onset_21 years) or young onset (between 21 and 40 years) Parkinson disease (YOPD). Methods: We studied 46 patients, mostly from Italy or Brazil, including 11 with juvenile parkinsonism and 35 with YOPD....
Uploaded on: April 14, 2023 -
2005 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: March 27, 2023